In case you were wondering how Pharma’s faring

money-pillsYesterday, I posted about the Joint Commission’s review of the unintended consequences of their emphasis on pain without the proper input, review and feedback systems.

The opioid crisis that this has contributed to have been a disaster for families, communities and health care professionals who are trying to navigate the standards, untrustworthy standards of care, and their medical/social consequences.

One might wonder how Pharma is faring in this crisis. Has there been regulatory, criminal, funding or popular backlash that has hurt their viability?

It would appear not.